Arvinas (ARVN) Cash & Current Investments (2017 - 2026)

Arvinas' (ARVN) quarterly Cash & Current Investments came in at $614.9 million in Q1 2026, down 35.57% year-on-year from $954.3 million in Q1 2025, and down 10.29% quarter-over-quarter from $685.4 million in Q4 2025.

Arvinas (ARVN) Cash & Current Investments (2017 - 2026) Analysis & Trends

Arvinas' Cash & Current Investments history runs 10 years deep, the most recent figure standing at $614.9 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 35.57% year-over-year to $614.9 million in Q1 2026; TTM through Mar 2026 was $614.9 million, a 35.57% decrease from a year earlier, with the FY2025 full-year figure at $685.4 million, down 34.06% from the prior year.
  • Cash & Current Investments retreated to $614.9 million in Q1 2026 per ARVN's latest filing, from $685.4 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $1.2 billion in Q1 2024 and bottomed at $66.8 million in Q1 2022.
  • The 5-year median for Cash & Current Investments is $160.3 million (2024), against an average of $436.2 million.
  • Across the five-year window, Cash & Current Investments sank 91.06% in 2022 and surged 824.41% in 2025, its largest moves.
  • Year by year, Cash & Current Investments stood at $86.8 million in 2022, then jumped by 265.44% to $317.2 million in 2023, then jumped by 227.68% to $1.0 billion in 2024, then slumped by 34.06% to $685.4 million in 2025, then retreated by 10.29% to $614.9 million in 2026.
  • Per Business Quant, the three latest ARVN Cash & Current Investments figures stand at $614.9 million (Q1 2026), $685.4 million (Q4 2025), and $787.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,801.52 Bn 66,801.23 Bn - 283.54 Mn
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn - 61.40 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 472.27 Bn 467.47 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 122.18 Bn 114.93 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 70.08 Bn 61.32 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn 5.18 Bn
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn 3.01 Bn
10 Arvinas 531.20 Mn -83.70 Mn - 614.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 614.90 Mn
Dec 31, 2025 685.40 Mn
Sep 30, 2025 787.60 Mn
Jun 30, 2025 861.20 Mn
Mar 31, 2025 954.30 Mn
Dec 31, 2024 1.04 Bn
Sep 30, 2024 85.20 Mn
Jun 30, 2024 160.30 Mn
Mar 31, 2024 1.17 Bn
Dec 31, 2023 317.20 Mn
Sep 30, 2023 119.20 Mn
Jun 30, 2023 96.10 Mn
Mar 31, 2023 135.70 Mn
Dec 31, 2022 86.80 Mn
Sep 30, 2022 138.10 Mn
Jun 30, 2022 97.70 Mn
Mar 31, 2022 66.80 Mn
Dec 31, 2021 112.80 Mn
Sep 30, 2021 1.54 Bn
Jun 30, 2021 53.23 Mn